Shares of Moderna Inc.
shed 3.17% to $156.78 Tuesday, on what proved to be an all-around grim buying and selling session for the inventory market, with the NASDAQ Composite Index
falling 0.92% to 13,786.27 and Dow Jones Industrial Common
falling 0.75% to 33,821.30. This was the inventory’s second consecutive day of losses. Moderna Inc. closed $32.48 in need of its 52-week excessive ($189.26), which the corporate reached on February eighth.
The inventory underperformed when in comparison with a few of its rivals Tuesday, as AbbVie Inc.
rose 0.39% to $109.03, Amgen Inc.
rose 1.24% to $259.14, and AstraZeneca PLC ADR
rose 1.24% to $52.27. Buying and selling quantity (7.1 M) remained 1.9 million beneath its 50-day common quantity of 9.0 M.